anmelden
Stoxx Europe 50
5.472,74
PKT
+11,86
PKT
+0,22
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.02.23 | Intesa Sanpaolo Overweight | Barclays Capital | |
| 06.02.23 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.23 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 06.02.23 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 05.02.23 | Intesa Sanpaolo Hold | Jefferies & Company Inc. | |
| 04.02.23 | Intesa Sanpaolo Buy | Goldman Sachs Group Inc. | |
| 04.02.23 | Santander Sector Perform | RBC Capital Markets | |
| 03.02.23 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 03.02.23 | BP Outperform | RBC Capital Markets | |
| 03.02.23 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 03.02.23 | Roche Outperform | Credit Suisse Group | |
| 03.02.23 | Intesa Sanpaolo Hold | Jefferies & Company Inc. | |
| 03.02.23 | ING Group Outperform | Credit Suisse Group | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.02.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.02.23 | Roche Sell | Deutsche Bank AG | |
| 03.02.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.02.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.02.23 | SAFRAN Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 03.02.23 | LVMH Moet Hennessy Louis Vuitton Buy | Jefferies & Company Inc. | |
| 03.02.23 | Santander Buy | Deutsche Bank AG | |
| 03.02.23 | ING Group Buy | Deutsche Bank AG | |
| 03.02.23 | Siemens Buy | Deutsche Bank AG | |
| 03.02.23 | Santander Outperform | Credit Suisse Group | |
| 03.02.23 | LOréal Neutral | JP Morgan Chase & Co. | |
| 03.02.23 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | ING Group Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.02.23 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.02.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.02.23 | ING Group Buy | Jefferies & Company Inc. | |
| 02.02.23 | Roche Hold | Jefferies & Company Inc. | |
| 02.02.23 | Santander Buy | Jefferies & Company Inc. | |
| 02.02.23 | Novartis Underperform | Credit Suisse Group | |
| 02.02.23 | LOréal Neutral | Credit Suisse Group | |
| 02.02.23 | Novo Nordisk Neutral | Credit Suisse Group |
